Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 141 entries
Sorted by: Best Match Show Resources per page
5-Cyclo-hexyl-4-methyl-1H-pyrazol-3(2H)-one monohydrate.

Acta crystallographica. Section E, Structure reports online

Shahani T, Fun HK, Ragavan RV, Vijayakumar V, Sarveswari S.
PMID: 21588963
Acta Crystallogr Sect E Struct Rep Online. 2010 Oct 09;66:o2760-1. doi: 10.1107/S1600536810039164.

In the title compound, C(10)H(16)N(2)O·H(2)O, the cyclo-hexane ring is in a chair conformation and its least-squares plane makes a dihedral angle of 53.68 (5)° with the approximately planar pyrazole ring [maximum deviation = 0.034 (1) Å]. Pairs of inter-molecular...

Cite
Shahani T, Fun HK, Ragavan RV, et al. 5-Cyclo-hexyl-4-methyl-1H-pyrazol-3(2H)-one monohydrate. Acta Crystallogr Sect E Struct Rep Online. 2010;66:o2760-1doi: 10.1107/S1600536810039164.
Shahani, T., Fun, H. K., Ragavan, R. V., Vijayakumar, V., & Sarveswari, S. (2010). 5-Cyclo-hexyl-4-methyl-1H-pyrazol-3(2H)-one monohydrate. Acta crystallographica. Section E, Structure reports online, 66o2760-1. https://doi.org/10.1107/S1600536810039164
Shahani, Tara, et al. "5-Cyclo-hexyl-4-methyl-1H-pyrazol-3(2H)-one monohydrate." Acta crystallographica. Section E, Structure reports online vol. 66 (2010): o2760-1. doi: https://doi.org/10.1107/S1600536810039164
Shahani T, Fun HK, Ragavan RV, Vijayakumar V, Sarveswari S. 5-Cyclo-hexyl-4-methyl-1H-pyrazol-3(2H)-one monohydrate. Acta Crystallogr Sect E Struct Rep Online. 2010 Oct 09;66:o2760-1. doi: 10.1107/S1600536810039164. PMID: 21588963; PMCID: PMC3009194.
Copy Download .nbib Format: NLM
4-{[5-(4-Chloro-phen-yl)-1-(4-fluoro-phen-yl)-1H-pyrazol-3-yl]carbon-yl}-N-ethyl-piperazine-1-carboxamide.

Acta crystallographica. Section E, Structure reports online

Shahani T, Fun HK, Vijayakumar V, Ragavan RV, Sarveswari S.
PMID: 21837133
Acta Crystallogr Sect E Struct Rep Online. 2011 Jul 01;67:o1747-8. doi: 10.1107/S1600536811023178. Epub 2011 Jun 18.

The asymmetric unit of the title compound, C(23)H(23)ClFN(5)O(2), contains two crystallographically independent mol-ecules. In one mol-ecule, the pyrazole ring makes dihedral angles of 43.93 (7) and 35.82 (7)°, respectively, with the fluoro- and chloro-substituted benzene rings, while the corresponding...

Cite
Shahani T, Fun HK, Vijayakumar V, et al. 4-{[5-(4-Chloro-phen-yl)-1-(4-fluoro-phen-yl)-1H-pyrazol-3-yl]carbon-yl}-N-ethyl-piperazine-1-carboxamide. Acta Crystallogr Sect E Struct Rep Online. 2011;67:o1747-8doi: 10.1107/S1600536811023178.
Shahani, T., Fun, H. K., Vijayakumar, V., Ragavan, R. V., & Sarveswari, S. (2011). 4-{[5-(4-Chloro-phen-yl)-1-(4-fluoro-phen-yl)-1H-pyrazol-3-yl]carbon-yl}-N-ethyl-piperazine-1-carboxamide. Acta crystallographica. Section E, Structure reports online, 67o1747-8. https://doi.org/10.1107/S1600536811023178
Shahani, Tara, et al. "4-{[5-(4-Chloro-phen-yl)-1-(4-fluoro-phen-yl)-1H-pyrazol-3-yl]carbon-yl}-N-ethyl-piperazine-1-carboxamide." Acta crystallographica. Section E, Structure reports online vol. 67 (2011): o1747-8. doi: https://doi.org/10.1107/S1600536811023178
Shahani T, Fun HK, Vijayakumar V, Ragavan RV, Sarveswari S. 4-{[5-(4-Chloro-phen-yl)-1-(4-fluoro-phen-yl)-1H-pyrazol-3-yl]carbon-yl}-N-ethyl-piperazine-1-carboxamide. Acta Crystallogr Sect E Struct Rep Online. 2011 Jul 01;67:o1747-8. doi: 10.1107/S1600536811023178. Epub 2011 Jun 18. PMID: 21837133; PMCID: PMC3151813.
Copy Download .nbib Format: NLM
1-(4-Fluoro-phen-yl)-3-methyl-4-phenyl-sulfanyl-1H-pyrazol-5(4H)-one.

Acta crystallographica. Section E, Structure reports online

Shahani T, Fun HK, Ragavan RV, Vijayakumar V, Venkatesh M.
PMID: 21589006
Acta Crystallogr Sect E Struct Rep Online. 2010 Oct 20;66:o2815-6. doi: 10.1107/S1600536810040596.

The title compound, C(16)H(13)FN(2)OS, has undergone enol-to-keto tautomerism during the crystallization process. The 1H-pyrazole-5-one ring [maximum deviation = 0.0198 (11) Å] is inclined at angles of 33.10 (5) and 79.57 (5)° with respect to the fluoro-phenyl [maximum deviation =...

Cite
Shahani T, Fun HK, Ragavan RV, et al. 1-(4-Fluoro-phen-yl)-3-methyl-4-phenyl-sulfanyl-1H-pyrazol-5(4H)-one. Acta Crystallogr Sect E Struct Rep Online. 2010;66:o2815-6doi: 10.1107/S1600536810040596.
Shahani, T., Fun, H. K., Ragavan, R. V., Vijayakumar, V., & Venkatesh, M. (2010). 1-(4-Fluoro-phen-yl)-3-methyl-4-phenyl-sulfanyl-1H-pyrazol-5(4H)-one. Acta crystallographica. Section E, Structure reports online, 66o2815-6. https://doi.org/10.1107/S1600536810040596
Shahani, Tara, et al. "1-(4-Fluoro-phen-yl)-3-methyl-4-phenyl-sulfanyl-1H-pyrazol-5(4H)-one." Acta crystallographica. Section E, Structure reports online vol. 66 (2010): o2815-6. doi: https://doi.org/10.1107/S1600536810040596
Shahani T, Fun HK, Ragavan RV, Vijayakumar V, Venkatesh M. 1-(4-Fluoro-phen-yl)-3-methyl-4-phenyl-sulfanyl-1H-pyrazol-5(4H)-one. Acta Crystallogr Sect E Struct Rep Online. 2010 Oct 20;66:o2815-6. doi: 10.1107/S1600536810040596. PMID: 21589006; PMCID: PMC3009262.
Copy Download .nbib Format: NLM
Evaluation of Freeze-Drying, Pasteurization, High-Temperature Heating and Storage on Selected Enzymes, B-Vitamins and Lipids of Mature Human Milk.

Journal of food protection

Friend BA, Shahani KM, Long CA, Agel EN.
PMID: 30913585
J Food Prot. 1983 Apr;46(4):330-334. doi: 10.4315/0362-028X-46.4.330.

The effects of freeze-drying, pasteurization, high-temperature heating and storage on key enzymes, B-vitamins and lipids of pooled mature human milk were determined. Freeze-drying significantly decreased (P

Cite
Friend BA, Shahani KM, Long CA, et al. Evaluation of Freeze-Drying, Pasteurization, High-Temperature Heating and Storage on Selected Enzymes, B-Vitamins and Lipids of Mature Human Milk. J Food Prot. 1983;46(4):330-334doi: 10.4315/0362-028X-46.4.330.
Friend, B. A., Shahani, K. M., Long, C. A., & Agel, E. N. (1983). Evaluation of Freeze-Drying, Pasteurization, High-Temperature Heating and Storage on Selected Enzymes, B-Vitamins and Lipids of Mature Human Milk. Journal of food protection, 46(4), 330-334. https://doi.org/10.4315/0362-028X-46.4.330
Friend, B A, et al. "Evaluation of Freeze-Drying, Pasteurization, High-Temperature Heating and Storage on Selected Enzymes, B-Vitamins and Lipids of Mature Human Milk." Journal of food protection vol. 46,4 (1983): 330-334. doi: https://doi.org/10.4315/0362-028X-46.4.330
Friend BA, Shahani KM, Long CA, Agel EN. Evaluation of Freeze-Drying, Pasteurization, High-Temperature Heating and Storage on Selected Enzymes, B-Vitamins and Lipids of Mature Human Milk. J Food Prot. 1983 Apr;46(4):330-334. doi: 10.4315/0362-028X-46.4.330. PMID: 30913585.
Copy Download .nbib Format: NLM
A side-by-side comparison of the solidification dynamics of quasicrystalline and approximant phases in the Al-Co-Ni system.

Acta crystallographica. Section A, Foundations and advances

Han I, Xiao X, Sun H, Shahani AJ.
PMID: 30821261
Acta Crystallogr A Found Adv. 2019 Mar 01;75:281-296. doi: 10.1107/S2053273318017114. Epub 2019 Feb 06.

Quasicrystals and their approximants have triggered widespread interest due to the challenge of solving their complex crystal structures as well as their possibly exceptional properties. The structural motifs of approximants are similar to those of the corresponding quasicrystals, but...

Cite
Han I, Xiao X, Sun H, et al. A side-by-side comparison of the solidification dynamics of quasicrystalline and approximant phases in the Al-Co-Ni system. Acta Crystallogr A Found Adv. 2019;75:281-296doi: 10.1107/S2053273318017114.
Han, I., Xiao, X., Sun, H., & Shahani, A. J. (2019). A side-by-side comparison of the solidification dynamics of quasicrystalline and approximant phases in the Al-Co-Ni system. Acta crystallographica. Section A, Foundations and advances, 75281-296. https://doi.org/10.1107/S2053273318017114
Han, Insung, et al. "A side-by-side comparison of the solidification dynamics of quasicrystalline and approximant phases in the Al-Co-Ni system." Acta crystallographica. Section A, Foundations and advances vol. 75 (2019): 281-296. doi: https://doi.org/10.1107/S2053273318017114
Han I, Xiao X, Sun H, Shahani AJ. A side-by-side comparison of the solidification dynamics of quasicrystalline and approximant phases in the Al-Co-Ni system. Acta Crystallogr A Found Adv. 2019 Mar 01;75:281-296. doi: 10.1107/S2053273318017114. Epub 2019 Feb 06. PMID: 30821261; PMCID: PMC6396399.
Copy Download .nbib Format: NLM
Evaluation of treatment adherence in outpatients with schizophrenia.

Industrial psychiatry journal

Chaudhari B, Saldanha D, Kadiani A, Shahani R.
PMID: 30089972
Ind Psychiatry J. 2017 Jul-Dec;26(2):215-222. doi: 10.4103/ipj.ipj_24_17.

BACKGROUND: Treatment nonadherence is a major obstacle in the successful management of schizophrenia. Finding out factors associated with nonadherence and the reasons for nonadherence are important to improve treatment adherence in patients with schizophrenia. This study was conceived to...

Cite
Chaudhari B, Saldanha D, Kadiani A, et al. Evaluation of treatment adherence in outpatients with schizophrenia. Ind Psychiatry J. 2017;26(2):215-222doi: 10.4103/ipj.ipj_24_17.
Chaudhari, B., Saldanha, D., Kadiani, A., & Shahani, R. (2017). Evaluation of treatment adherence in outpatients with schizophrenia. Industrial psychiatry journal, 26(2), 215-222. https://doi.org/10.4103/ipj.ipj_24_17
Chaudhari, Bhushan, et al. "Evaluation of treatment adherence in outpatients with schizophrenia." Industrial psychiatry journal vol. 26,2 (2017): 215-222. doi: https://doi.org/10.4103/ipj.ipj_24_17
Chaudhari B, Saldanha D, Kadiani A, Shahani R. Evaluation of treatment adherence in outpatients with schizophrenia. Ind Psychiatry J. 2017 Jul-Dec;26(2):215-222. doi: 10.4103/ipj.ipj_24_17. PMID: 30089972; PMCID: PMC6058450.
Copy Download .nbib Format: NLM
Draft Genome Sequence of Pseudomonas gingeri Strain LMG 5327, the Causative Agent of Ginger Blotch in Agaricus bisporus.

Genome announcements

Bahrami T, Zarvandi S, De Mot R, Gross H, Changi-Ashtiani M, Shahani T, Rokni-Zadeh H.
PMID: 29599158
Genome Announc. 2018 Mar 29;6(13). doi: 10.1128/genomeA.00196-18.

The draft genome sequence of

Cite
Bahrami T, Zarvandi S, De Mot R, et al. Draft Genome Sequence of Pseudomonas gingeri Strain LMG 5327, the Causative Agent of Ginger Blotch in Agaricus bisporus. Genome Announc. 2018;6(13)doi: 10.1128/genomeA.00196-18.
Bahrami, T., Zarvandi, S., De Mot, R., Gross, H., Changi-Ashtiani, M., Shahani, T., & Rokni-Zadeh, H. (2018). Draft Genome Sequence of Pseudomonas gingeri Strain LMG 5327, the Causative Agent of Ginger Blotch in Agaricus bisporus. Genome announcements, 6(13), . https://doi.org/10.1128/genomeA.00196-18
Bahrami, Tahereh, et al. "Draft Genome Sequence of Pseudomonas gingeri Strain LMG 5327, the Causative Agent of Ginger Blotch in Agaricus bisporus." Genome announcements vol. 6,13 (2018). doi: https://doi.org/10.1128/genomeA.00196-18
Bahrami T, Zarvandi S, De Mot R, Gross H, Changi-Ashtiani M, Shahani T, Rokni-Zadeh H. Draft Genome Sequence of Pseudomonas gingeri Strain LMG 5327, the Causative Agent of Ginger Blotch in Agaricus bisporus. Genome Announc. 2018 Mar 29;6(13). doi: 10.1128/genomeA.00196-18. PMID: 29599158; PMCID: PMC5876480.
Copy Download .nbib Format: NLM
Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics.

Frontiers in oncology

Hernandez JJ, Pryszlak M, Smith L, Yanchus C, Kurji N, Shahani VM, Molinski SV.
PMID: 29184849
Front Oncol. 2017 Nov 14;7:273. doi: 10.3389/fonc.2017.00273. eCollection 2017.

The repositioning or "repurposing" of existing therapies for alternative disease indications is an attractive approach that can save significant investments of time and money during drug development. For cancer indications, the primary goal of repurposed therapies is on efficacy,...

Cite
Hernandez JJ, Pryszlak M, Smith L, et al. Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics. Front Oncol. 2017;7:273doi: 10.3389/fonc.2017.00273.
Hernandez, J. J., Pryszlak, M., Smith, L., Yanchus, C., Kurji, N., Shahani, V. M., & Molinski, S. V. (2017). Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics. Frontiers in oncology, 7273. https://doi.org/10.3389/fonc.2017.00273
Hernandez, J Javier, et al. "Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics." Frontiers in oncology vol. 7 (2017): 273. doi: https://doi.org/10.3389/fonc.2017.00273
Hernandez JJ, Pryszlak M, Smith L, Yanchus C, Kurji N, Shahani VM, Molinski SV. Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics. Front Oncol. 2017 Nov 14;7:273. doi: 10.3389/fonc.2017.00273. eCollection 2017. PMID: 29184849; PMCID: PMC5694537.
Copy Download .nbib Format: NLM
2,3-Dibromo-3-(5-nitro-2-fur-yl)-1-phenyl-propan-1-one.

Acta crystallographica. Section E, Structure reports online

Shahani T, Fun HK, Nithinchandra, Kalluraya B.
PMID: 21522313
Acta Crystallogr Sect E Struct Rep Online. 2011 Feb 02;67:o546. doi: 10.1107/S1600536811003552.

In the title compound, C(13)H(9)Br(2)NO(4), the phenyl and 2-nitro-furan rings are linked by a 2,3-dibromo-propanal group, six atoms of which, including a furyl C atom, are disordered over two positions with a site-occupancy ratio of 0.733 (11):0.267 (11). The...

Cite
Shahani T, Fun HK, Nithinchandra, et al. 2,3-Dibromo-3-(5-nitro-2-fur-yl)-1-phenyl-propan-1-one. Acta Crystallogr Sect E Struct Rep Online. 2011;67:o546doi: 10.1107/S1600536811003552.
Shahani, T., Fun, H. K., Nithinchandra, & Kalluraya, B. (2011). 2,3-Dibromo-3-(5-nitro-2-fur-yl)-1-phenyl-propan-1-one. Acta crystallographica. Section E, Structure reports online, 67o546. https://doi.org/10.1107/S1600536811003552
Shahani, Tara, et al. "2,3-Dibromo-3-(5-nitro-2-fur-yl)-1-phenyl-propan-1-one." Acta crystallographica. Section E, Structure reports online vol. 67 (2011): o546. doi: https://doi.org/10.1107/S1600536811003552
Shahani T, Fun HK, Nithinchandra, Kalluraya B. 2,3-Dibromo-3-(5-nitro-2-fur-yl)-1-phenyl-propan-1-one. Acta Crystallogr Sect E Struct Rep Online. 2011 Feb 02;67:o546. doi: 10.1107/S1600536811003552. PMID: 21522313; PMCID: PMC3052152.
Copy Download .nbib Format: NLM
Effects of 3 Hz and 60 Hz Extremely Low Frequency Electromagnetic Fields on Anxiety-Like Behaviors, Memory Retention of Passive Avoidance and Electrophysiological Properties of Male Rats.

Journal of lasers in medical sciences

Rostami A, Shahani M, Zarrindast MR, Semnanian S, Rahmati Roudsari M, Rezaei Tavirani M, Hasanzadeh H.
PMID: 27330708
J Lasers Med Sci. 2016;7(2):120-5. doi: 10.15171/jlms.2016.20. Epub 2016 Mar 27.

INTRODUCTION: The effects of electromagnetic fields on biological organisms have been a controversial and also interesting debate over the past few decades, despite the wide range of investigations, many aspects of extremely low frequency electromagnetic fields (ELF/EMFs) effects including...

Cite
Rostami A, Shahani M, Zarrindast MR, et al. Effects of 3 Hz and 60 Hz Extremely Low Frequency Electromagnetic Fields on Anxiety-Like Behaviors, Memory Retention of Passive Avoidance and Electrophysiological Properties of Male Rats. J Lasers Med Sci. 2016;7(2):120-5doi: 10.15171/jlms.2016.20.
Rostami, A., Shahani, M., Zarrindast, M. R., Semnanian, S., Rahmati Roudsari, M., Rezaei Tavirani, M., & Hasanzadeh, H. (2016). Effects of 3 Hz and 60 Hz Extremely Low Frequency Electromagnetic Fields on Anxiety-Like Behaviors, Memory Retention of Passive Avoidance and Electrophysiological Properties of Male Rats. Journal of lasers in medical sciences, 7(2), 120-5. https://doi.org/10.15171/jlms.2016.20
Rostami, Amin, et al. "Effects of 3 Hz and 60 Hz Extremely Low Frequency Electromagnetic Fields on Anxiety-Like Behaviors, Memory Retention of Passive Avoidance and Electrophysiological Properties of Male Rats." Journal of lasers in medical sciences vol. 7,2 (2016): 120-5. doi: https://doi.org/10.15171/jlms.2016.20
Rostami A, Shahani M, Zarrindast MR, Semnanian S, Rahmati Roudsari M, Rezaei Tavirani M, Hasanzadeh H. Effects of 3 Hz and 60 Hz Extremely Low Frequency Electromagnetic Fields on Anxiety-Like Behaviors, Memory Retention of Passive Avoidance and Electrophysiological Properties of Male Rats. J Lasers Med Sci. 2016;7(2):120-5. doi: 10.15171/jlms.2016.20. Epub 2016 Mar 27. PMID: 27330708; PMCID: PMC4909017.
Copy Download .nbib Format: NLM
Male Infertility, Precision Medicine and Systems Proteomics.

Journal of reproduction & infertility

Agharezaee N, Hashemi M, Shahani M, Gilany K.
PMID: 30746333
J Reprod Infertil. 2018 Oct-Dec;19(4):185-192.

Precision medicine (PM) is an approach that has the power to create the best effect and safety of medicine and treatment with the least side effects for each person. PM is very helpful as sometimes due to inaccurate or...

Cite
Agharezaee N, Hashemi M, Shahani M, et al. Male Infertility, Precision Medicine and Systems Proteomics. J Reprod Infertil. 2018;19(4):185-192
Agharezaee, N., Hashemi, M., Shahani, M., & Gilany, K. (2018). Male Infertility, Precision Medicine and Systems Proteomics. Journal of reproduction & infertility, 19(4), 185-192.
Agharezaee, Niloofar, et al. "Male Infertility, Precision Medicine and Systems Proteomics." Journal of reproduction & infertility vol. 19,4 (2018): 185-192.
Agharezaee N, Hashemi M, Shahani M, Gilany K. Male Infertility, Precision Medicine and Systems Proteomics. J Reprod Infertil. 2018 Oct-Dec;19(4):185-192. PMID: 30746333; PMCID: PMC6328981.
Copy Download .nbib Format: NLM
Commentary: models can be powerful tools for making decisions about effective and efficient health care.

BMJ (Clinical research ed.)

Shahani A.
PMID: 8898600
BMJ. 1996 Oct 26;313(7064):1057. doi: 10.1136/bmj.313.7064.1057.
Free PMC Article

No abstract available.

Cite
Shahani A. Commentary: models can be powerful tools for making decisions about effective and efficient health care. BMJ. 1996;313(7064):1057doi: 10.1136/bmj.313.7064.1057.
Shahani, A. (1996). Commentary: models can be powerful tools for making decisions about effective and efficient health care. BMJ (Clinical research ed.), 313(7064), 1057. https://doi.org/10.1136/bmj.313.7064.1057
Shahani, A. "Commentary: models can be powerful tools for making decisions about effective and efficient health care." BMJ (Clinical research ed.) vol. 313,7064 (1996): 1057. doi: https://doi.org/10.1136/bmj.313.7064.1057
Shahani A. Commentary: models can be powerful tools for making decisions about effective and efficient health care. BMJ. 1996 Oct 26;313(7064):1057. doi: 10.1136/bmj.313.7064.1057. PMID: 8898600; PMCID: PMC2352354.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 141 entries